nodes	percent_of_prediction	percent_of_DWPC	metapath
Difluprednate—NR3C1—hypertension	0.432	1	CbGaD
Difluprednate—NR3C1—Spironolactone—hypertension	0.121	1	CbGbCtD
Difluprednate—Megestrol acetate—Spironolactone—hypertension	0.105	0.374	CrCrCtD
Difluprednate—Cortisone acetate—Eplerenone—hypertension	0.094	0.335	CrCrCtD
Difluprednate—Cortisone acetate—Spironolactone—hypertension	0.0818	0.291	CrCrCtD
Difluprednate—Anterior chamber flare—Timolol—hypertension	0.00464	0.0416	CcSEcCtD
Difluprednate—Scleral hyperaemia—Timolol—hypertension	0.00464	0.0416	CcSEcCtD
Difluprednate—Uveitis—Reserpine—hypertension	0.00368	0.033	CcSEcCtD
Difluprednate—Conjunctival hyperaemia—Reserpine—hypertension	0.00293	0.0262	CcSEcCtD
Difluprednate—Panophthalmitis—Diltiazem—hypertension	0.00264	0.0236	CcSEcCtD
Difluprednate—Iritis—Guanfacine—hypertension	0.00235	0.0211	CcSEcCtD
Difluprednate—Panophthalmitis—Betaxolol—hypertension	0.00194	0.0174	CcSEcCtD
Difluprednate—Conjunctival oedema—Trandolapril—hypertension	0.00191	0.0171	CcSEcCtD
Difluprednate—Punctate keratitis—Betaxolol—hypertension	0.00187	0.0168	CcSEcCtD
Difluprednate—NR3C1—FOXA2 and FOXA3 transcription factor networks—FOXF1—hypertension	0.00178	0.0431	CbGpPWpGaD
Difluprednate—Conjunctival oedema—Betaxolol—hypertension	0.0017	0.0153	CcSEcCtD
Difluprednate—Pregnancy—Quinapril—hypertension	0.00164	0.0147	CcSEcCtD
Difluprednate—Macular oedema—Timolol—hypertension	0.00158	0.0142	CcSEcCtD
Difluprednate—Punctate keratitis—Timolol—hypertension	0.00153	0.0137	CcSEcCtD
Difluprednate—Sensation of foreign body—Betaxolol—hypertension	0.00145	0.013	CcSEcCtD
Difluprednate—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—SRF—hypertension	0.00141	0.0343	CbGpPWpGaD
Difluprednate—NR3C1—urine—hypertension	0.00135	0.201	CbGeAlD
Difluprednate—Endophthalmitis—Diltiazem—hypertension	0.00135	0.0121	CcSEcCtD
Difluprednate—Hyperaemia—Timolol—hypertension	0.00128	0.0115	CcSEcCtD
Difluprednate—Blepharitis—Nisoldipine—hypertension	0.00125	0.0112	CcSEcCtD
Difluprednate—Iritis—Betaxolol—hypertension	0.00124	0.0112	CcSEcCtD
Difluprednate—Scab—Timolol—hypertension	0.00121	0.0109	CcSEcCtD
Difluprednate—Sensation of foreign body—Timolol—hypertension	0.00119	0.0106	CcSEcCtD
Difluprednate—Pregnancy—Fosinopril—hypertension	0.0011	0.00984	CcSEcCtD
Difluprednate—Lacrimation increased—Hydralazine—hypertension	0.00104	0.00932	CcSEcCtD
Difluprednate—Endophthalmitis—Betaxolol—hypertension	0.000993	0.0089	CcSEcCtD
Difluprednate—NR3C1—Signaling events mediated by HDAC Class II—HDAC5—hypertension	0.000918	0.0222	CbGpPWpGaD
Difluprednate—Pregnancy—Captopril—hypertension	0.000892	0.00799	CcSEcCtD
Difluprednate—NR3C1—Regulation of Androgen receptor activity—RCHY1—hypertension	0.00088	0.0213	CbGpPWpGaD
Difluprednate—Conjunctival hyperaemia—Timolol—hypertension	0.000878	0.00787	CcSEcCtD
Difluprednate—Eye pain—Prazosin—hypertension	0.000872	0.00782	CcSEcCtD
Difluprednate—Herpes simplex—Eprosartan—hypertension	0.000861	0.00772	CcSEcCtD
Difluprednate—Blepharitis—Trandolapril—hypertension	0.000861	0.00772	CcSEcCtD
Difluprednate—Eye irritation—Metoprolol—hypertension	0.000848	0.00761	CcSEcCtD
Difluprednate—Dry eye—Nadolol—hypertension	0.000842	0.00755	CcSEcCtD
Difluprednate—Lacrimation increased—Nisoldipine—hypertension	0.000836	0.0075	CcSEcCtD
Difluprednate—Herpes simplex—Nisoldipine—hypertension	0.000836	0.0075	CcSEcCtD
Difluprednate—NR3C1—Signaling events mediated by HDAC Class II—SRF—hypertension	0.000813	0.0197	CbGpPWpGaD
Difluprednate—Endophthalmitis—Timolol—hypertension	0.000811	0.00727	CcSEcCtD
Difluprednate—NR3C1—Endoderm Differentiation—GATA6—hypertension	0.000809	0.0196	CbGpPWpGaD
Difluprednate—Visual acuity reduced—Betaxolol—hypertension	0.000795	0.00713	CcSEcCtD
Difluprednate—Blepharitis—Betaxolol—hypertension	0.000769	0.00689	CcSEcCtD
Difluprednate—Dry eye—Acebutolol—hypertension	0.000764	0.00685	CcSEcCtD
Difluprednate—Dry eye—Labetalol—hypertension	0.000757	0.00679	CcSEcCtD
Difluprednate—Eye irritation—Diltiazem—hypertension	0.000754	0.00676	CcSEcCtD
Difluprednate—Weight increased—Reserpine—hypertension	0.000735	0.00659	CcSEcCtD
Difluprednate—Eye irritation—Fosinopril—hypertension	0.00073	0.00654	CcSEcCtD
Difluprednate—NR3C1—Nuclear Receptor transcription pathway—NR3C2—hypertension	0.000706	0.0171	CbGpPWpGaD
Difluprednate—Herpes simplex—Doxazosin—hypertension	0.000684	0.00614	CcSEcCtD
Difluprednate—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—HTR7—hypertension	0.000684	0.0166	CbGpPWpGaD
Difluprednate—Dry eye—Metoprolol—hypertension	0.000669	0.006	CcSEcCtD
Difluprednate—Eye pain—Acebutolol—hypertension	0.000665	0.00596	CcSEcCtD
Difluprednate—NR3C1—FOXA2 and FOXA3 transcription factor networks—UCP2—hypertension	0.000658	0.0159	CbGpPWpGaD
Difluprednate—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—EGR1—hypertension	0.000656	0.0159	CbGpPWpGaD
Difluprednate—Visual acuity reduced—Timolol—hypertension	0.000649	0.00582	CcSEcCtD
Difluprednate—Vision blurred—Mecamylamine—hypertension	0.000639	0.00573	CcSEcCtD
Difluprednate—NR3C1—Transcription factor regulation in adipogenesis—ADIPOQ—hypertension	0.000637	0.0154	CbGpPWpGaD
Difluprednate—NR3C1—FOXA2 and FOXA3 transcription factor networks—ALAS1—hypertension	0.000637	0.0154	CbGpPWpGaD
Difluprednate—Blepharitis—Timolol—hypertension	0.000628	0.00563	CcSEcCtD
Difluprednate—Eye pain—Amlodipine—hypertension	0.00062	0.00556	CcSEcCtD
Difluprednate—Dry eye—Propranolol—hypertension	0.000614	0.00551	CcSEcCtD
Difluprednate—Photophobia—Indapamide—hypertension	0.000605	0.00542	CcSEcCtD
Difluprednate—NR3C1—Transcription factor regulation in adipogenesis—SLC2A4—hypertension	0.000602	0.0146	CbGpPWpGaD
Difluprednate—Photophobia—Doxazosin—hypertension	0.000592	0.00531	CcSEcCtD
Difluprednate—NR3C1—Signaling events mediated by HDAC Class II—HDAC6—hypertension	0.000592	0.0143	CbGpPWpGaD
Difluprednate—Lacrimation increased—Enalapril—hypertension	0.000572	0.00513	CcSEcCtD
Difluprednate—Amcinonide—ANXA1—hypertension	0.00057	0.101	CrCbGaD
Difluprednate—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—GNAS—hypertension	0.000568	0.0138	CbGpPWpGaD
Difluprednate—NR3C1—FOXA2 and FOXA3 transcription factor networks—KCNJ11—hypertension	0.00056	0.0136	CbGpPWpGaD
Difluprednate—Weight increased—Methyldopa—hypertension	0.000557	0.00499	CcSEcCtD
Difluprednate—Eye irritation—Betaxolol—hypertension	0.000554	0.00496	CcSEcCtD
Difluprednate—Weight increased—Pindolol—hypertension	0.00054	0.00484	CcSEcCtD
Difluprednate—Lacrimation increased—Perindopril—hypertension	0.000533	0.00478	CcSEcCtD
Difluprednate—Vision blurred—Ethacrynic acid—hypertension	0.00053	0.00476	CcSEcCtD
Difluprednate—NR3C1—cardiac ventricle—hypertension	0.000528	0.0783	CbGeAlD
Difluprednate—Weight increased—Nadolol—hypertension	0.00052	0.00467	CcSEcCtD
Difluprednate—NR3C1—Transcription factor regulation in adipogenesis—PPARGC1A—hypertension	0.000519	0.0126	CbGpPWpGaD
Difluprednate—Lacrimation increased—Betaxolol—hypertension	0.000513	0.0046	CcSEcCtD
Difluprednate—Weight increased—Isradipine—hypertension	0.000512	0.00459	CcSEcCtD
Difluprednate—Weight increased—Guanfacine—hypertension	0.00051	0.00458	CcSEcCtD
Difluprednate—Eye pain—Doxazosin—hypertension	0.000507	0.00455	CcSEcCtD
Difluprednate—Dry eye—Clonidine—hypertension	0.000502	0.0045	CcSEcCtD
Difluprednate—NR3C1—myocardium—hypertension	0.000497	0.0736	CbGeAlD
Difluprednate—Eye pain—Nifedipine—hypertension	0.000494	0.00443	CcSEcCtD
Difluprednate—Dry eye—Enalapril—hypertension	0.000487	0.00437	CcSEcCtD
Difluprednate—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—F7—hypertension	0.000487	0.0118	CbGpPWpGaD
Difluprednate—Weight increased—Terazosin—hypertension	0.000484	0.00434	CcSEcCtD
Difluprednate—Weight increased—Acebutolol—hypertension	0.000472	0.00423	CcSEcCtD
Difluprednate—Dry eye—Captopril—hypertension	0.000467	0.00419	CcSEcCtD
Difluprednate—Vision blurred—Chlorothiazide—hypertension	0.000458	0.00411	CcSEcCtD
Difluprednate—Eye irritation—Timolol—hypertension	0.000452	0.00406	CcSEcCtD
Difluprednate—Vision blurred—Prazosin—hypertension	0.000447	0.00401	CcSEcCtD
Difluprednate—NR3C1—AP-1 transcription factor network—NFATC2—hypertension	0.000447	0.0108	CbGpPWpGaD
Difluprednate—Photophobia—Betaxolol—hypertension	0.000444	0.00398	CcSEcCtD
Difluprednate—Weight increased—Amlodipine—hypertension	0.00044	0.00395	CcSEcCtD
Difluprednate—Weight increased—Nisoldipine—hypertension	0.00044	0.00395	CcSEcCtD
Difluprednate—Dry eye—Betaxolol—hypertension	0.000437	0.00392	CcSEcCtD
Difluprednate—NR3C1—Glucocorticoid receptor regulatory network—SGK1—hypertension	0.00043	0.0104	CbGpPWpGaD
Difluprednate—Vision blurred—Bepridil—hypertension	0.000422	0.00379	CcSEcCtD
Difluprednate—Lacrimation increased—Timolol—hypertension	0.000419	0.00376	CcSEcCtD
Difluprednate—Weight increased—Metoprolol—hypertension	0.000414	0.00371	CcSEcCtD
Difluprednate—Weight increased—Guanabenz—hypertension	0.000414	0.00371	CcSEcCtD
Difluprednate—NR3C1—Signaling events mediated by HDAC Class II—ADRBK1—hypertension	0.000406	0.00983	CbGpPWpGaD
Difluprednate—NR3C1—Endoderm Differentiation—GATA4—hypertension	0.000404	0.00979	CbGpPWpGaD
Difluprednate—NR3C1—Nuclear Receptors—ESR2—hypertension	0.000403	0.00975	CbGpPWpGaD
Difluprednate—NR3C1—brainstem—hypertension	0.000401	0.0594	CbGeAlD
Difluprednate—NR3C1—Transcription factor regulation in adipogenesis—LEP—hypertension	0.000396	0.00959	CbGpPWpGaD
Difluprednate—NR3C1—Adipogenesis—RETN—hypertension	0.000393	0.00951	CbGpPWpGaD
Difluprednate—NR3C1—AP-1 transcription factor network—DUSP1—hypertension	0.00039	0.00946	CbGpPWpGaD
Difluprednate—Eye pain—Betaxolol—hypertension	0.00038	0.00341	CcSEcCtD
Difluprednate—Vision blurred—Nadolol—hypertension	0.000375	0.00337	CcSEcCtD
Difluprednate—Vision blurred—Isradipine—hypertension	0.00037	0.00331	CcSEcCtD
Difluprednate—Vision blurred—Guanfacine—hypertension	0.000368	0.0033	CcSEcCtD
Difluprednate—Weight increased—Diltiazem—hypertension	0.000368	0.0033	CcSEcCtD
Difluprednate—Vision blurred—Nicardipine—hypertension	0.000367	0.00329	CcSEcCtD
Difluprednate—NR3C1—nephron tubule—hypertension	0.000364	0.054	CbGeAlD
Difluprednate—Weight increased—Carvedilol—hypertension	0.000364	0.00326	CcSEcCtD
Difluprednate—Vision blurred—Metolazone—hypertension	0.000363	0.00325	CcSEcCtD
Difluprednate—Photophobia—Timolol—hypertension	0.000363	0.00325	CcSEcCtD
Difluprednate—Weight increased—Doxazosin—hypertension	0.00036	0.00323	CcSEcCtD
Difluprednate—NR3C1—adrenal cortex—hypertension	0.000358	0.0531	CbGeAlD
Difluprednate—Dry eye—Timolol—hypertension	0.000357	0.0032	CcSEcCtD
Difluprednate—Weight increased—Fosinopril—hypertension	0.000356	0.00319	CcSEcCtD
Difluprednate—NR3C1—Nuclear Receptors—AR—hypertension	0.000356	0.00862	CbGpPWpGaD
Difluprednate—NR3C1—Circadian Clock—F7—hypertension	0.000355	0.0086	CbGpPWpGaD
Difluprednate—Weight increased—Nifedipine—hypertension	0.000351	0.00315	CcSEcCtD
Difluprednate—Vision blurred—Terazosin—hypertension	0.000349	0.00313	CcSEcCtD
Difluprednate—NR3C1—heart—hypertension	0.000347	0.0514	CbGeAlD
Difluprednate—NR3C1—Transcription factor regulation in adipogenesis—PPARG—hypertension	0.000345	0.00836	CbGpPWpGaD
Difluprednate—NR3C1—AP-1 transcription factor network—NPPA—hypertension	0.000344	0.00834	CbGpPWpGaD
Difluprednate—NR3C1—smooth muscle tissue—hypertension	0.000344	0.051	CbGeAlD
Difluprednate—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—PPARGC1A—hypertension	0.000342	0.00829	CbGpPWpGaD
Difluprednate—Headache—Triamterene—hypertension	0.000342	0.00306	CcSEcCtD
Difluprednate—Vision blurred—Acebutolol—hypertension	0.000341	0.00305	CcSEcCtD
Difluprednate—NR3C1—SIDS Susceptibility Pathways—KCNJ8—hypertension	0.000339	0.00822	CbGpPWpGaD
Difluprednate—NR3C1—SIDS Susceptibility Pathways—KCNQ1—hypertension	0.000339	0.00822	CbGpPWpGaD
Difluprednate—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—AVP—hypertension	0.000338	0.00818	CbGpPWpGaD
Difluprednate—Vision blurred—Labetalol—hypertension	0.000338	0.00303	CcSEcCtD
Difluprednate—NR3C1—decidua—hypertension	0.000337	0.05	CbGeAlD
Difluprednate—Photophobia—Lisinopril—hypertension	0.000336	0.00302	CcSEcCtD
Difluprednate—NR3C1—Regulation of nuclear SMAD2/3 signaling—MYOD1—hypertension	0.000329	0.00798	CbGpPWpGaD
Difluprednate—NR3C1—cardiovascular system—hypertension	0.000327	0.0485	CbGeAlD
Difluprednate—Pruritus—Reserpine—hypertension	0.000325	0.00291	CcSEcCtD
Difluprednate—NR3C1—kidney—hypertension	0.00032	0.0474	CbGeAlD
Difluprednate—NR3C1—Nuclear Receptors—VDR—hypertension	0.000319	0.00774	CbGpPWpGaD
Difluprednate—NR3C1—Nuclear Receptor transcription pathway—ESR2—hypertension	0.000318	0.00771	CbGpPWpGaD
Difluprednate—NR3C1—SIDS Susceptibility Pathways—ECE1—hypertension	0.000316	0.00765	CbGpPWpGaD
Difluprednate—NR3C1—cortex of kidney—hypertension	0.000312	0.0462	CbGeAlD
Difluprednate—Eye pain—Timolol—hypertension	0.000311	0.00278	CcSEcCtD
Difluprednate—Weight increased—Clonidine—hypertension	0.00031	0.00278	CcSEcCtD
Difluprednate—Pruritus—Nebivolol—hypertension	0.000306	0.00274	CcSEcCtD
Difluprednate—NR3C1—Glucocorticoid receptor regulatory network—SELE—hypertension	0.000303	0.00735	CbGpPWpGaD
Difluprednate—Vision blurred—Guanabenz—hypertension	0.000298	0.00268	CcSEcCtD
Difluprednate—Vision blurred—Metoprolol—hypertension	0.000298	0.00268	CcSEcCtD
Difluprednate—NR3C1—cardiac atrium—hypertension	0.000296	0.0439	CbGeAlD
Difluprednate—Headache—Hydroflumethiazide—hypertension	0.000296	0.00266	CcSEcCtD
Difluprednate—NR3C1—Regulation of Androgen receptor activity—EGR1—hypertension	0.000289	0.00699	CbGpPWpGaD
Difluprednate—Headache—Reserpine—hypertension	0.000288	0.00258	CcSEcCtD
Difluprednate—Headache—Ethacrynic acid—hypertension	0.000288	0.00258	CcSEcCtD
Difluprednate—NR3C1—Adipogenesis—MIF—hypertension	0.000286	0.00694	CbGpPWpGaD
Difluprednate—NR3C1—Adipogenesis—PTGIS—hypertension	0.000286	0.00694	CbGpPWpGaD
Difluprednate—NR3C1—SIDS Susceptibility Pathways—SLC9A3—hypertension	0.000281	0.00681	CbGpPWpGaD
Difluprednate—NR3C1—Nuclear Receptor transcription pathway—AR—hypertension	0.000281	0.00681	CbGpPWpGaD
Difluprednate—NR3C1—Regulation of Androgen receptor activity—HDAC1—hypertension	0.00028	0.00679	CbGpPWpGaD
Difluprednate—Weight increased—Irbesartan—hypertension	0.00028	0.00251	CcSEcCtD
Difluprednate—NR3C1—medulla oblongata—hypertension	0.000279	0.0414	CbGeAlD
Difluprednate—Headache—Fenoldopam—hypertension	0.000278	0.00249	CcSEcCtD
Difluprednate—Weight increased—Hydrochlorothiazide—hypertension	0.000277	0.00249	CcSEcCtD
Difluprednate—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—PPARA—hypertension	0.000275	0.00667	CbGpPWpGaD
Difluprednate—Pruritus—Bumetanide—hypertension	0.000274	0.00245	CcSEcCtD
Difluprednate—Pruritus—Prazosin—hypertension	0.000274	0.00245	CcSEcCtD
Difluprednate—NR3C1—Regulation of Androgen receptor activity—AR—hypertension	0.000272	0.0066	CbGpPWpGaD
Difluprednate—Headache—Nebivolol—hypertension	0.000271	0.00243	CcSEcCtD
Difluprednate—Weight increased—Betaxolol—hypertension	0.00027	0.00242	CcSEcCtD
Difluprednate—NR3C1—Nuclear Receptors—PPARA—hypertension	0.000269	0.00653	CbGpPWpGaD
Difluprednate—NR3C1—Glucocorticoid receptor regulatory network—IL13—hypertension	0.000269	0.00651	CbGpPWpGaD
Difluprednate—Vision blurred—Indapamide—hypertension	0.000265	0.00238	CcSEcCtD
Difluprednate—Vision blurred—Diltiazem—hypertension	0.000265	0.00238	CcSEcCtD
Difluprednate—Fluticasone Propionate—NR3C2—hypertension	0.000264	0.0467	CrCbGaD
Difluprednate—Weight increased—Losartan—hypertension	0.000263	0.00236	CcSEcCtD
Difluprednate—Vision blurred—Carvedilol—hypertension	0.000263	0.00236	CcSEcCtD
Difluprednate—NR3C1—AP-1 transcription factor network—TIMP1—hypertension	0.000261	0.00632	CbGpPWpGaD
Difluprednate—Vision blurred—Doxazosin—hypertension	0.00026	0.00233	CcSEcCtD
Difluprednate—NR3C1—adrenal gland—hypertension	0.000259	0.0383	CbGeAlD
Difluprednate—Vision blurred—Fosinopril—hypertension	0.000257	0.0023	CcSEcCtD
Difluprednate—Headache—Torasemide—hypertension	0.000255	0.00229	CcSEcCtD
Difluprednate—Vision blurred—Nifedipine—hypertension	0.000253	0.00227	CcSEcCtD
Difluprednate—NR3C1—Nuclear Receptor transcription pathway—VDR—hypertension	0.000252	0.00612	CbGpPWpGaD
Difluprednate—Vision blurred—Verapamil—hypertension	0.000252	0.00226	CcSEcCtD
Difluprednate—Pruritus—Candesartan—hypertension	0.00025	0.00224	CcSEcCtD
Difluprednate—NR3C1—Circadian Clock—PPARGC1A—hypertension	0.000249	0.00604	CbGpPWpGaD
Difluprednate—Headache—Chlorothiazide—hypertension	0.000249	0.00223	CcSEcCtD
Difluprednate—NR3C1—Circadian Clock—AVP—hypertension	0.000246	0.00596	CbGpPWpGaD
Difluprednate—NR3C1—AP-1 transcription factor network—TH—hypertension	0.000245	0.00594	CbGpPWpGaD
Difluprednate—Headache—Chlorthalidone—hypertension	0.000244	0.00219	CcSEcCtD
Difluprednate—Headache—Bumetanide—hypertension	0.000242	0.00217	CcSEcCtD
Difluprednate—Headache—Prazosin—hypertension	0.000242	0.00217	CcSEcCtD
Difluprednate—Pruritus—Amiloride—hypertension	0.000242	0.00217	CcSEcCtD
Difluprednate—Pruritus—Hydralazine—hypertension	0.000242	0.00217	CcSEcCtD
Difluprednate—Betamethasone—NR3C2—hypertension	0.000242	0.0428	CrCbGaD
Difluprednate—NR3C1—Adipogenesis—GATA4—hypertension	0.000241	0.00583	CbGpPWpGaD
Difluprednate—NR3C1—SIDS Susceptibility Pathways—TPH1—hypertension	0.000239	0.00579	CbGpPWpGaD
Difluprednate—Pruritus—Pindolol—hypertension	0.000239	0.00214	CcSEcCtD
Difluprednate—Vision blurred—Valsartan—hypertension	0.000235	0.0021	CcSEcCtD
Difluprednate—Pruritus—Quinapril—hypertension	0.000235	0.0021	CcSEcCtD
Difluprednate—Vision blurred—Olmesartan—hypertension	0.000234	0.00209	CcSEcCtD
Difluprednate—NR3C1—Transcription factor regulation in adipogenesis—MAPK8—hypertension	0.000231	0.00561	CbGpPWpGaD
Difluprednate—NR3C1—AP-1 transcription factor network—EGR1—hypertension	0.000231	0.0056	CbGpPWpGaD
Difluprednate—Pruritus—Benazepril—hypertension	0.000231	0.00207	CcSEcCtD
Difluprednate—Pruritus—Nadolol—hypertension	0.00023	0.00206	CcSEcCtD
Difluprednate—Headache—Bepridil—hypertension	0.000229	0.00205	CcSEcCtD
Difluprednate—Headache—Penbutolol—hypertension	0.000227	0.00203	CcSEcCtD
Difluprednate—Dexamethasone—CYP4A11—hypertension	0.000227	0.0402	CrCbGaD
Difluprednate—Pruritus—Isradipine—hypertension	0.000227	0.00203	CcSEcCtD
Difluprednate—Pruritus—Guanfacine—hypertension	0.000226	0.00202	CcSEcCtD
Difluprednate—Weight increased—Ramipril—hypertension	0.000226	0.00202	CcSEcCtD
Difluprednate—NR3C1—FOXA2 and FOXA3 transcription factor networks—APOA1—hypertension	0.000225	0.00545	CbGpPWpGaD
Difluprednate—NR3C1—endocrine gland—hypertension	0.000224	0.0333	CbGeAlD
Difluprednate—Vision blurred—Clonidine—hypertension	0.000224	0.00201	CcSEcCtD
Difluprednate—NR3C1—Nuclear Receptors—PPARG—hypertension	0.000223	0.0054	CbGpPWpGaD
Difluprednate—Pruritus—Metolazone—hypertension	0.000222	0.00199	CcSEcCtD
Difluprednate—Pruritus—Felodipine—hypertension	0.000222	0.00199	CcSEcCtD
Difluprednate—Pruritus—Spironolactone—hypertension	0.000222	0.00199	CcSEcCtD
Difluprednate—Headache—Candesartan—hypertension	0.000221	0.00198	CcSEcCtD
Difluprednate—NR3C1—AP-1 transcription factor network—GJA1—hypertension	0.00022	0.00533	CbGpPWpGaD
Difluprednate—Headache—Methyldopa—hypertension	0.000218	0.00196	CcSEcCtD
Difluprednate—Vision blurred—Enalapril—hypertension	0.000217	0.00195	CcSEcCtD
Difluprednate—Pruritus—Esmolol—hypertension	0.000217	0.00195	CcSEcCtD
Difluprednate—NR3C1—Adipogenesis—AHR—hypertension	0.000215	0.00521	CbGpPWpGaD
Difluprednate—NR3C1—FOXA2 and FOXA3 transcription factor networks—F2—hypertension	0.000214	0.0052	CbGpPWpGaD
Difluprednate—Headache—Hydralazine—hypertension	0.000214	0.00192	CcSEcCtD
Difluprednate—Headache—Amiloride—hypertension	0.000214	0.00192	CcSEcCtD
Difluprednate—Pruritus—Terazosin—hypertension	0.000214	0.00192	CcSEcCtD
Difluprednate—NR3C1—Nuclear Receptor transcription pathway—PPARA—hypertension	0.000213	0.00516	CbGpPWpGaD
Difluprednate—Headache—Pindolol—hypertension	0.000211	0.00189	CcSEcCtD
Difluprednate—Pruritus—Acebutolol—hypertension	0.000209	0.00187	CcSEcCtD
Difluprednate—Vision blurred—Captopril—hypertension	0.000208	0.00187	CcSEcCtD
Difluprednate—NR3C1—SIDS Susceptibility Pathways—HADHA—hypertension	0.000208	0.00504	CbGpPWpGaD
Difluprednate—Headache—Quinapril—hypertension	0.000208	0.00186	CcSEcCtD
Difluprednate—Pruritus—Labetalol—hypertension	0.000207	0.00185	CcSEcCtD
Difluprednate—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—SERPINE1—hypertension	0.000205	0.00497	CbGpPWpGaD
Difluprednate—Weight increased—Lisinopril—hypertension	0.000205	0.00183	CcSEcCtD
Difluprednate—Headache—Benazepril—hypertension	0.000204	0.00183	CcSEcCtD
Difluprednate—NR3C1—Glucocorticoid receptor regulatory network—EGR1—hypertension	0.000204	0.00493	CbGpPWpGaD
Difluprednate—NR3C1—SIDS Susceptibility Pathways—AQP4—hypertension	0.000203	0.00493	CbGpPWpGaD
Difluprednate—NR3C1—central nervous system—hypertension	0.000202	0.03	CbGeAlD
Difluprednate—Vision blurred—Irbesartan—hypertension	0.000202	0.00181	CcSEcCtD
Difluprednate—Headache—Isradipine—hypertension	0.000201	0.0018	CcSEcCtD
Difluprednate—NR3C1—Circadian Clock—PPARA—hypertension	0.0002	0.00486	CbGpPWpGaD
Difluprednate—NR3C1—Glucocorticoid receptor regulatory network—PRL—hypertension	0.0002	0.00486	CbGpPWpGaD
Difluprednate—Pruritus—Eprosartan—hypertension	0.0002	0.0018	CcSEcCtD
Difluprednate—Vision blurred—Hydrochlorothiazide—hypertension	0.0002	0.00179	CcSEcCtD
Difluprednate—Headache—Guanfacine—hypertension	0.0002	0.00179	CcSEcCtD
Difluprednate—NR3C1—Regulation of nuclear SMAD2/3 signaling—HDAC1—hypertension	0.0002	0.00483	CbGpPWpGaD
Difluprednate—Headache—Nicardipine—hypertension	0.000199	0.00178	CcSEcCtD
Difluprednate—NR3C1—Glucocorticoid receptor regulatory network—HDAC1—hypertension	0.000198	0.00479	CbGpPWpGaD
Difluprednate—Headache—Felodipine—hypertension	0.000197	0.00177	CcSEcCtD
Difluprednate—Headache—Metolazone—hypertension	0.000197	0.00177	CcSEcCtD
Difluprednate—Vision blurred—Furosemide—hypertension	0.000197	0.00176	CcSEcCtD
Difluprednate—Headache—Spironolactone—hypertension	0.000196	0.00176	CcSEcCtD
Difluprednate—NR3C1—Circadian Clock—HIF1A—hypertension	0.000195	0.00472	CbGpPWpGaD
Difluprednate—Vision blurred—Betaxolol—hypertension	0.000195	0.00175	CcSEcCtD
Difluprednate—Pruritus—Amlodipine—hypertension	0.000195	0.00174	CcSEcCtD
Difluprednate—Pruritus—Nisoldipine—hypertension	0.000195	0.00174	CcSEcCtD
Difluprednate—NR3C1—FOXA2 and FOXA3 transcription factor networks—INS—hypertension	0.000194	0.00471	CbGpPWpGaD
Difluprednate—NR3C1—Regulation of nuclear SMAD2/3 signaling—AR—hypertension	0.000194	0.0047	CbGpPWpGaD
Difluprednate—NR3C1—AP-1 transcription factor network—EDN1—hypertension	0.000193	0.00467	CbGpPWpGaD
Difluprednate—Headache—Esmolol—hypertension	0.000192	0.00172	CcSEcCtD
Difluprednate—NR3C1—SIDS Susceptibility Pathways—HSPD1—hypertension	0.000191	0.00463	CbGpPWpGaD
Difluprednate—NR3C1—AP-1 transcription factor network—IL10—hypertension	0.000191	0.00462	CbGpPWpGaD
Difluprednate—Vision blurred—Losartan—hypertension	0.00019	0.0017	CcSEcCtD
Difluprednate—Headache—Terazosin—hypertension	0.00019	0.0017	CcSEcCtD
Difluprednate—Prednicarbate—NR3C1—hypertension	0.000186	0.0329	CrCbGaD
Difluprednate—Clocortolone—NR3C1—hypertension	0.000186	0.0329	CrCbGaD
Difluprednate—Headache—Acebutolol—hypertension	0.000185	0.00166	CcSEcCtD
Difluprednate—Headache—Labetalol—hypertension	0.000183	0.00164	CcSEcCtD
Difluprednate—NR3C1—Transcription factor regulation in adipogenesis—TNF—hypertension	0.000183	0.00444	CbGpPWpGaD
Difluprednate—Pruritus—Guanabenz—hypertension	0.000183	0.00164	CcSEcCtD
Difluprednate—Pruritus—Metoprolol—hypertension	0.000183	0.00164	CcSEcCtD
Difluprednate—NR3C1—SIDS Susceptibility Pathways—TACR1—hypertension	0.000181	0.00439	CbGpPWpGaD
Difluprednate—Dexamethasone—ANXA1—hypertension	0.000179	0.0318	CrCbGaD
Difluprednate—NR3C1—FOXA2 and FOXA3 transcription factor networks—ALB—hypertension	0.000178	0.00432	CbGpPWpGaD
Difluprednate—Headache—Eprosartan—hypertension	0.000177	0.00159	CcSEcCtD
Difluprednate—NR3C1—Nuclear Receptor transcription pathway—PPARG—hypertension	0.000176	0.00427	CbGpPWpGaD
Difluprednate—Diflorasone—NR3C1—hypertension	0.000176	0.0312	CrCbGaD
Difluprednate—NR3C1—Regulation of nuclear SMAD2/3 signaling—VDR—hypertension	0.000174	0.00423	CbGpPWpGaD
Difluprednate—Headache—Nisoldipine—hypertension	0.000172	0.00154	CcSEcCtD
Difluprednate—Headache—Amlodipine—hypertension	0.000172	0.00154	CcSEcCtD
Difluprednate—Desoximetasone—NR3C1—hypertension	0.000171	0.0304	CrCbGaD
Difluprednate—NR3C1—Regulation of nuclear SMAD2/3 signaling—IL10—hypertension	0.00017	0.00411	CbGpPWpGaD
Difluprednate—Pruritus—Diltiazem—hypertension	0.000163	0.00146	CcSEcCtD
Difluprednate—Pruritus—Indapamide—hypertension	0.000163	0.00146	CcSEcCtD
Difluprednate—NR3C1—AP-1 transcription factor network—MMP1—hypertension	0.000162	0.00393	CbGpPWpGaD
Difluprednate—Headache—Metoprolol—hypertension	0.000162	0.00145	CcSEcCtD
Difluprednate—Headache—Guanabenz—hypertension	0.000162	0.00145	CcSEcCtD
Difluprednate—Pruritus—Carvedilol—hypertension	0.000161	0.00144	CcSEcCtD
Difluprednate—NR3C1—AP-1 transcription factor network—HIF1A—hypertension	0.000161	0.00389	CbGpPWpGaD
Difluprednate—NR3C1—SIDS Susceptibility Pathways—IL13—hypertension	0.000161	0.00389	CbGpPWpGaD
Difluprednate—Beclomethasone—CYP3A5—hypertension	0.00016	0.0284	CrCbGaD
Difluprednate—NR3C1—AP-1 transcription factor network—AGT—hypertension	0.00016	0.00388	CbGpPWpGaD
Difluprednate—Pruritus—Doxazosin—hypertension	0.000159	0.00143	CcSEcCtD
Difluprednate—Vision blurred—Timolol—hypertension	0.000159	0.00143	CcSEcCtD
Difluprednate—Pruritus—Fosinopril—hypertension	0.000157	0.00141	CcSEcCtD
Difluprednate—Pruritus—Eplerenone—hypertension	0.000156	0.0014	CcSEcCtD
Difluprednate—Pruritus—Nifedipine—hypertension	0.000155	0.00139	CcSEcCtD
Difluprednate—Pruritus—Verapamil—hypertension	0.000154	0.00138	CcSEcCtD
Difluprednate—NR3C1—Adipogenesis—ADIPOQ—hypertension	0.000154	0.00373	CbGpPWpGaD
Difluprednate—NR3C1—Circadian Clock—SERPINE1—hypertension	0.000149	0.00362	CbGpPWpGaD
Difluprednate—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—EP300—hypertension	0.000149	0.00361	CbGpPWpGaD
Difluprednate—NR3C1—Endoderm Differentiation—NOTCH1—hypertension	0.000148	0.00359	CbGpPWpGaD
Difluprednate—NR3C1—Transcription factor regulation in adipogenesis—IL6—hypertension	0.000148	0.00358	CbGpPWpGaD
Difluprednate—NR3C1—SIDS Susceptibility Pathways—TAC1—hypertension	0.000148	0.00358	CbGpPWpGaD
Difluprednate—Vision blurred—Lisinopril—hypertension	0.000148	0.00132	CcSEcCtD
Difluprednate—Flumethasone Pivalate—NR3C1—hypertension	0.000148	0.0262	CrCbGaD
Difluprednate—NR3C1—Adipogenesis—SLC2A4—hypertension	0.000145	0.00352	CbGpPWpGaD
Difluprednate—Halobetasol Propionate—NR3C1—hypertension	0.000145	0.0257	CrCbGaD
Difluprednate—NR3C1—SIDS Susceptibility Pathways—SLC6A4—hypertension	0.000145	0.00351	CbGpPWpGaD
Difluprednate—Headache—Diltiazem—hypertension	0.000144	0.00129	CcSEcCtD
Difluprednate—Headache—Indapamide—hypertension	0.000144	0.00129	CcSEcCtD
Difluprednate—Pruritus—Valsartan—hypertension	0.000144	0.00129	CcSEcCtD
Difluprednate—Pruritus—Olmesartan—hypertension	0.000143	0.00128	CcSEcCtD
Difluprednate—Cortisone acetate—NR3C1—hypertension	0.000143	0.0253	CrCbGaD
Difluprednate—NR3C1—Glucocorticoid receptor regulatory network—MMP1—hypertension	0.000143	0.00346	CbGpPWpGaD
Difluprednate—Headache—Carvedilol—hypertension	0.000143	0.00128	CcSEcCtD
Difluprednate—Headache—Doxazosin—hypertension	0.000141	0.00126	CcSEcCtD
Difluprednate—NR3C1—SIDS Susceptibility Pathways—SST—hypertension	0.000141	0.00341	CbGpPWpGaD
Difluprednate—Dexamethasone—NR3C2—hypertension	0.000141	0.0249	CrCbGaD
Difluprednate—NR3C1—SIDS Susceptibility Pathways—IL1RN—hypertension	0.00014	0.0034	CbGpPWpGaD
Difluprednate—Headache—Fosinopril—hypertension	0.000139	0.00125	CcSEcCtD
Difluprednate—Headache—Eplerenone—hypertension	0.000138	0.00124	CcSEcCtD
Difluprednate—Megestrol acetate—NR3C1—hypertension	0.000138	0.0244	CrCbGaD
Difluprednate—Headache—Nifedipine—hypertension	0.000137	0.00123	CcSEcCtD
Difluprednate—Pruritus—Clonidine—hypertension	0.000137	0.00123	CcSEcCtD
Difluprednate—Headache—Verapamil—hypertension	0.000137	0.00123	CcSEcCtD
Difluprednate—Amcinonide—NR3C1—hypertension	0.000135	0.0239	CrCbGaD
Difluprednate—NR3C1—AP-1 transcription factor network—FOS—hypertension	0.000135	0.00327	CbGpPWpGaD
Difluprednate—Pruritus—Trandolapril—hypertension	0.000134	0.0012	CcSEcCtD
Difluprednate—Pruritus—Enalapril—hypertension	0.000133	0.00119	CcSEcCtD
Difluprednate—Fluticasone furoate—NR3C1—hypertension	0.000132	0.0235	CrCbGaD
Difluprednate—NR3C1—AP-1 transcription factor network—CCL2—hypertension	0.000132	0.00319	CbGpPWpGaD
Difluprednate—Pruritus—Telmisartan—hypertension	0.000131	0.00118	CcSEcCtD
Difluprednate—NR3C1—SIDS Susceptibility Pathways—ESR2—hypertension	0.00013	0.00315	CbGpPWpGaD
Difluprednate—NR3C1—Glucocorticoid receptor regulatory network—ICAM1—hypertension	0.00013	0.00315	CbGpPWpGaD
Difluprednate—NR3C1—SIDS Susceptibility Pathways—TH—hypertension	0.000129	0.00313	CbGpPWpGaD
Difluprednate—Mometasone—NR3C1—hypertension	0.000128	0.0228	CrCbGaD
Difluprednate—Pruritus—Captopril—hypertension	0.000128	0.00115	CcSEcCtD
Difluprednate—Headache—Valsartan—hypertension	0.000127	0.00114	CcSEcCtD
Difluprednate—Rimexolone—NR3C1—hypertension	0.000127	0.0225	CrCbGaD
Difluprednate—Headache—Olmesartan—hypertension	0.000127	0.00114	CcSEcCtD
Difluprednate—NR3C1—Adipogenesis—PPARGC1A—hypertension	0.000125	0.00304	CbGpPWpGaD
Difluprednate—Pruritus—Perindopril—hypertension	0.000124	0.00111	CcSEcCtD
Difluprednate—Pruritus—Irbesartan—hypertension	0.000124	0.00111	CcSEcCtD
Difluprednate—Pruritus—Hydrochlorothiazide—hypertension	0.000123	0.0011	CcSEcCtD
Difluprednate—NR3C1—Generic Transcription Pathway—NR3C2—hypertension	0.000122	0.00295	CbGpPWpGaD
Difluprednate—NR3C1—SIDS Susceptibility Pathways—EGR1—hypertension	0.000122	0.00295	CbGpPWpGaD
Difluprednate—Headache—Clonidine—hypertension	0.000121	0.00109	CcSEcCtD
Difluprednate—Pruritus—Furosemide—hypertension	0.000121	0.00108	CcSEcCtD
Difluprednate—NR3C1—Regulation of nuclear SMAD2/3 signaling—FOS—hypertension	0.00012	0.00291	CbGpPWpGaD
Difluprednate—Beclomethasone—NR3C1—hypertension	0.00012	0.0212	CrCbGaD
Difluprednate—Fluocinonide—NR3C1—hypertension	0.00012	0.0212	CrCbGaD
Difluprednate—Pruritus—Betaxolol—hypertension	0.000119	0.00107	CcSEcCtD
Difluprednate—NR3C1—Glucocorticoid receptor regulatory network—FOS—hypertension	0.000119	0.00288	CbGpPWpGaD
Difluprednate—NR3C1—Glucocorticoid receptor regulatory network—POMC—hypertension	0.000119	0.00288	CbGpPWpGaD
Difluprednate—Headache—Trandolapril—hypertension	0.000118	0.00106	CcSEcCtD
Difluprednate—NR3C1—SIDS Susceptibility Pathways—HDAC1—hypertension	0.000118	0.00286	CbGpPWpGaD
Difluprednate—Headache—Enalapril—hypertension	0.000118	0.00106	CcSEcCtD
Difluprednate—Fluocinolone Acetonide—NR3C1—hypertension	0.000116	0.0206	CrCbGaD
Difluprednate—Pruritus—Losartan—hypertension	0.000116	0.00104	CcSEcCtD
Difluprednate—Headache—Telmisartan—hypertension	0.000116	0.00104	CcSEcCtD
Difluprednate—NR3C1—SIDS Susceptibility Pathways—GJA1—hypertension	0.000116	0.00281	CbGpPWpGaD
Difluprednate—NR3C1—AP-1 transcription factor network—CDKN2A—hypertension	0.000115	0.00279	CbGpPWpGaD
Difluprednate—NR3C1—SIDS Susceptibility Pathways—AR—hypertension	0.000115	0.00278	CbGpPWpGaD
Difluprednate—NR3C1—Regulation of Androgen receptor activity—MAPK8—hypertension	0.000115	0.00278	CbGpPWpGaD
Difluprednate—NR3C1—Adipogenesis—LPL—hypertension	0.000114	0.00276	CbGpPWpGaD
Difluprednate—Clobetasol propionate—NR3C1—hypertension	0.000113	0.0201	CrCbGaD
Difluprednate—Flunisolide—NR3C1—hypertension	0.000113	0.0201	CrCbGaD
Difluprednate—Headache—Captopril—hypertension	0.000113	0.00101	CcSEcCtD
Difluprednate—Paramethasone—NR3C1—hypertension	0.000112	0.0198	CrCbGaD
Difluprednate—NR3C1—Regulation of Androgen receptor activity—EP300—hypertension	0.000112	0.00271	CbGpPWpGaD
Difluprednate—Headache—Perindopril—hypertension	0.00011	0.000984	CcSEcCtD
Difluprednate—NR3C1—Regulation of nuclear SMAD2/3 signaling—SERPINE1—hypertension	0.00011	0.00265	CbGpPWpGaD
Difluprednate—Headache—Irbesartan—hypertension	0.000109	0.000981	CcSEcCtD
Difluprednate—Fluorometholone—NR3C1—hypertension	0.000109	0.0194	CrCbGaD
Difluprednate—NR3C1—Regulation of Androgen receptor activity—SRC—hypertension	0.000109	0.00263	CbGpPWpGaD
Difluprednate—Headache—Hydrochlorothiazide—hypertension	0.000109	0.000973	CcSEcCtD
Difluprednate—NR3C1—Circadian Clock—EP300—hypertension	0.000108	0.00263	CbGpPWpGaD
Difluprednate—NR3C1—SIDS Susceptibility Pathways—PPARGC1A—hypertension	0.000108	0.00262	CbGpPWpGaD
Difluprednate—NR3C1—SIDS Susceptibility Pathways—GNB3—hypertension	0.000108	0.00262	CbGpPWpGaD
Difluprednate—NR3C1—SIDS Susceptibility Pathways—AVP—hypertension	0.000107	0.00259	CbGpPWpGaD
Difluprednate—Headache—Furosemide—hypertension	0.000107	0.000957	CcSEcCtD
Difluprednate—Fluticasone Propionate—CYP3A5—hypertension	0.000107	0.0189	CrCbGaD
Difluprednate—Headache—Betaxolol—hypertension	0.000106	0.000948	CcSEcCtD
Difluprednate—Methylprednisolone—NR3C1—hypertension	0.000106	0.0187	CrCbGaD
Difluprednate—NR3C1—AP-1 transcription factor network—CXCL8—hypertension	0.000104	0.00253	CbGpPWpGaD
Difluprednate—Headache—Losartan—hypertension	0.000103	0.000923	CcSEcCtD
Difluprednate—Dexamethasone—CYP17A1—hypertension	0.000103	0.0182	CrCbGaD
Difluprednate—Clobetasol propionate—CYP1A1—hypertension	0.000103	0.0182	CrCbGaD
Difluprednate—Dexamethasone—CYP11A1—hypertension	0.000101	0.0179	CrCbGaD
Difluprednate—NR3C1—Generic Transcription Pathway—NEDD4L—hypertension	0.000101	0.00245	CbGpPWpGaD
Difluprednate—NR3C1—Adipogenesis—PPARA—hypertension	0.000101	0.00244	CbGpPWpGaD
Difluprednate—NR3C1—SIDS Susceptibility Pathways—IL10—hypertension	0.0001	0.00243	CbGpPWpGaD
Difluprednate—Pruritus—Ramipril—hypertension	9.97e-05	0.000894	CcSEcCtD
Difluprednate—NR3C1—Adipogenesis—HIF1A—hypertension	9.79e-05	0.00237	CbGpPWpGaD
Difluprednate—NR3C1—Adipogenesis—AGT—hypertension	9.76e-05	0.00236	CbGpPWpGaD
Difluprednate—Pruritus—Timolol—hypertension	9.75e-05	0.000874	CcSEcCtD
Difluprednate—NR3C1—Glucocorticoid receptor regulatory network—RELA—hypertension	9.75e-05	0.00236	CbGpPWpGaD
Difluprednate—NR3C1—Adipogenesis—LEP—hypertension	9.56e-05	0.00232	CbGpPWpGaD
Difluprednate—NR3C1—SIDS Susceptibility Pathways—YWHAZ—hypertension	9.44e-05	0.00229	CbGpPWpGaD
Difluprednate—NR3C1—AP-1 transcription factor network—MMP9—hypertension	9.43e-05	0.00228	CbGpPWpGaD
Difluprednate—NR3C1—AP-1 transcription factor network—PTEN—hypertension	9.37e-05	0.00227	CbGpPWpGaD
Difluprednate—NR3C1—SIDS Susceptibility Pathways—NGF—hypertension	9.34e-05	0.00226	CbGpPWpGaD
Difluprednate—NR3C1—Glucocorticoid receptor regulatory network—CXCL8—hypertension	9.18e-05	0.00223	CbGpPWpGaD
Difluprednate—Pruritus—Lisinopril—hypertension	9.04e-05	0.000811	CcSEcCtD
Difluprednate—Betamethasone—CYP19A1—hypertension	9e-05	0.016	CrCbGaD
Difluprednate—NR3C1—AP-1 transcription factor network—EP300—hypertension	8.94e-05	0.00217	CbGpPWpGaD
Difluprednate—Triamcinolone—NR3C1—hypertension	8.9e-05	0.0158	CrCbGaD
Difluprednate—NR3C1—SIDS Susceptibility Pathways—HTR2A—hypertension	8.89e-05	0.00215	CbGpPWpGaD
Difluprednate—Headache—Ramipril—hypertension	8.83e-05	0.000792	CcSEcCtD
Difluprednate—NR3C1—Generic Transcription Pathway—GATA4—hypertension	8.79e-05	0.00213	CbGpPWpGaD
Difluprednate—Headache—Timolol—hypertension	8.63e-05	0.000774	CcSEcCtD
Difluprednate—NR3C1—SIDS Susceptibility Pathways—HIF1A—hypertension	8.46e-05	0.00205	CbGpPWpGaD
Difluprednate—Dexamethasone—NOS2—hypertension	8.39e-05	0.0149	CrCbGaD
Difluprednate—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDKN1A—hypertension	8.36e-05	0.00203	CbGpPWpGaD
Difluprednate—NR3C1—Adipogenesis—PPARG—hypertension	8.33e-05	0.00202	CbGpPWpGaD
Difluprednate—NR3C1—Glucocorticoid receptor regulatory network—CDKN1A—hypertension	8.28e-05	0.00201	CbGpPWpGaD
Difluprednate—NR3C1—Adipogenesis—INS—hypertension	8.17e-05	0.00198	CbGpPWpGaD
Difluprednate—NR3C1—Glucocorticoid receptor regulatory network—MAPK8—hypertension	8.08e-05	0.00196	CbGpPWpGaD
Difluprednate—Headache—Lisinopril—hypertension	8.01e-05	0.000718	CcSEcCtD
Difluprednate—Fluticasone Propionate—NR3C1—hypertension	7.96e-05	0.0141	CrCbGaD
Difluprednate—NR3C1—Regulation of nuclear SMAD2/3 signaling—EP300—hypertension	7.95e-05	0.00193	CbGpPWpGaD
Difluprednate—NR3C1—Endoderm Differentiation—TGFB1—hypertension	7.95e-05	0.00193	CbGpPWpGaD
Difluprednate—NR3C1—Adipogenesis—IGF1—hypertension	7.9e-05	0.00191	CbGpPWpGaD
Difluprednate—NR3C1—Glucocorticoid receptor regulatory network—EP300—hypertension	7.88e-05	0.00191	CbGpPWpGaD
Difluprednate—NR3C1—FOXA2 and FOXA3 transcription factor networks—AKT1—hypertension	7.83e-05	0.0019	CbGpPWpGaD
Difluprednate—NR3C1—AP-1 transcription factor network—MYC—hypertension	7.79e-05	0.00189	CbGpPWpGaD
Difluprednate—NR3C1—AP-1 transcription factor network—TGFB1—hypertension	7.77e-05	0.00188	CbGpPWpGaD
Difluprednate—NR3C1—Generic Transcription Pathway—NPPA—hypertension	7.66e-05	0.00186	CbGpPWpGaD
Difluprednate—NR3C1—Adipogenesis—SERPINE1—hypertension	7.5e-05	0.00182	CbGpPWpGaD
Difluprednate—Betamethasone—NR3C1—hypertension	7.29e-05	0.0129	CrCbGaD
Difluprednate—NR3C1—Regulation of nuclear SMAD2/3 signaling—MYC—hypertension	6.93e-05	0.00168	CbGpPWpGaD
Difluprednate—NR3C1—AP-1 transcription factor network—TP53—hypertension	6.4e-05	0.00155	CbGpPWpGaD
Difluprednate—NR3C1—Generic Transcription Pathway—CTGF—hypertension	6.01e-05	0.00146	CbGpPWpGaD
Difluprednate—NR3C1—Gene Expression—NR3C2—hypertension	5.87e-05	0.00142	CbGpPWpGaD
Difluprednate—NR3C1—AP-1 transcription factor network—IL6—hypertension	5.86e-05	0.00142	CbGpPWpGaD
Difluprednate—NR3C1—Adipogenesis—CDKN1A—hypertension	5.73e-05	0.00139	CbGpPWpGaD
Difluprednate—Dexamethasone—CYP3A5—hypertension	5.68e-05	0.0101	CrCbGaD
Difluprednate—NR3C1—Glucocorticoid receptor regulatory network—TP53—hypertension	5.64e-05	0.00137	CbGpPWpGaD
Difluprednate—NR3C1—Generic Transcription Pathway—ESR2—hypertension	5.49e-05	0.00133	CbGpPWpGaD
Difluprednate—NR3C1—SIDS Susceptibility Pathways—CXCL8—hypertension	5.49e-05	0.00133	CbGpPWpGaD
Difluprednate—NR3C1—SIDS Susceptibility Pathways—IL1B—hypertension	5.27e-05	0.00128	CbGpPWpGaD
Difluprednate—Dexamethasone—CYP19A1—hypertension	5.23e-05	0.00928	CrCbGaD
Difluprednate—NR3C1—Generic Transcription Pathway—NOTCH2—hypertension	5.2e-05	0.00126	CbGpPWpGaD
Difluprednate—NR3C1—Glucocorticoid receptor regulatory network—IL6—hypertension	5.16e-05	0.00125	CbGpPWpGaD
Difluprednate—Triamcinolone—PTGS2—hypertension	5.05e-05	0.00895	CrCbGaD
Difluprednate—NR3C1—Generic Transcription Pathway—HDAC1—hypertension	4.99e-05	0.00121	CbGpPWpGaD
Difluprednate—NR3C1—Gene Expression—NEDD4L—hypertension	4.86e-05	0.00118	CbGpPWpGaD
Difluprednate—NR3C1—Generic Transcription Pathway—AR—hypertension	4.85e-05	0.00118	CbGpPWpGaD
Difluprednate—NR3C1—Regulation of nuclear SMAD2/3 signaling—AKT1—hypertension	4.81e-05	0.00116	CbGpPWpGaD
Difluprednate—NR3C1—Glucocorticoid receptor regulatory network—AKT1—hypertension	4.76e-05	0.00115	CbGpPWpGaD
Difluprednate—NR3C1—Adipogenesis—TGFB1—hypertension	4.74e-05	0.00115	CbGpPWpGaD
Difluprednate—NR3C1—SIDS Susceptibility Pathways—EP300—hypertension	4.71e-05	0.00114	CbGpPWpGaD
Difluprednate—NR3C1—SIDS Susceptibility Pathways—VEGFA—hypertension	4.46e-05	0.00108	CbGpPWpGaD
Difluprednate—NR3C1—Adipogenesis—TNF—hypertension	4.42e-05	0.00107	CbGpPWpGaD
Difluprednate—NR3C1—Generic Transcription Pathway—VDR—hypertension	4.36e-05	0.00106	CbGpPWpGaD
Difluprednate—Dexamethasone—NR3C1—hypertension	4.24e-05	0.00752	CrCbGaD
Difluprednate—NR3C1—Gene Expression—GATA4—hypertension	4.23e-05	0.00103	CbGpPWpGaD
Difluprednate—Betamethasone—PTGS2—hypertension	4.14e-05	0.00733	CrCbGaD
Difluprednate—Dexamethasone—CYP1A1—hypertension	3.85e-05	0.00683	CrCbGaD
Difluprednate—NR3C1—SIDS Susceptibility Pathways—TNF—hypertension	3.82e-05	0.000926	CbGpPWpGaD
Difluprednate—NR3C1—Gene Expression—NPPA—hypertension	3.69e-05	0.000893	CbGpPWpGaD
Difluprednate—NR3C1—Generic Transcription Pathway—PPARA—hypertension	3.68e-05	0.000891	CbGpPWpGaD
Difluprednate—NR3C1—Adipogenesis—IL6—hypertension	3.57e-05	0.000865	CbGpPWpGaD
Difluprednate—NR3C1—Generic Transcription Pathway—NOTCH1—hypertension	3.22e-05	0.000781	CbGpPWpGaD
Difluprednate—NR3C1—SIDS Susceptibility Pathways—IL6—hypertension	3.08e-05	0.000747	CbGpPWpGaD
Difluprednate—NR3C1—Generic Transcription Pathway—PPARG—hypertension	3.04e-05	0.000737	CbGpPWpGaD
Difluprednate—NR3C1—Gene Expression—CTGF—hypertension	2.89e-05	0.000701	CbGpPWpGaD
Difluprednate—NR3C1—Generic Transcription Pathway—SERPINE1—hypertension	2.74e-05	0.000664	CbGpPWpGaD
Difluprednate—NR3C1—Gene Expression—ESR2—hypertension	2.65e-05	0.000641	CbGpPWpGaD
Difluprednate—NR3C1—Gene Expression—NOTCH2—hypertension	2.51e-05	0.000607	CbGpPWpGaD
Difluprednate—Dexamethasone—PTGS2—hypertension	2.41e-05	0.00427	CrCbGaD
Difluprednate—NR3C1—Gene Expression—HDAC1—hypertension	2.4e-05	0.000582	CbGpPWpGaD
Difluprednate—NR3C1—Gene Expression—AR—hypertension	2.34e-05	0.000566	CbGpPWpGaD
Difluprednate—NR3C1—Gene Expression—VDR—hypertension	2.1e-05	0.000509	CbGpPWpGaD
Difluprednate—NR3C1—Gene Expression—H2AFX—hypertension	1.99e-05	0.000482	CbGpPWpGaD
Difluprednate—NR3C1—Gene Expression—PRKCA—hypertension	1.94e-05	0.000469	CbGpPWpGaD
Difluprednate—NR3C1—Gene Expression—YWHAZ—hypertension	1.92e-05	0.000465	CbGpPWpGaD
Difluprednate—NR3C1—Gene Expression—PRKCD—hypertension	1.85e-05	0.000448	CbGpPWpGaD
Difluprednate—NR3C1—Gene Expression—PPARA—hypertension	1.77e-05	0.000429	CbGpPWpGaD
Difluprednate—NR3C1—Generic Transcription Pathway—MYC—hypertension	1.73e-05	0.00042	CbGpPWpGaD
Difluprednate—NR3C1—Gene Expression—NOTCH1—hypertension	1.55e-05	0.000376	CbGpPWpGaD
Difluprednate—NR3C1—Gene Expression—PPARG—hypertension	1.46e-05	0.000355	CbGpPWpGaD
Difluprednate—NR3C1—Gene Expression—SERPINE1—hypertension	1.32e-05	0.00032	CbGpPWpGaD
Difluprednate—NR3C1—Gene Expression—MYC—hypertension	8.35e-06	0.000202	CbGpPWpGaD
Difluprednate—NR3C1—Gene Expression—AKT1—hypertension	5.79e-06	0.00014	CbGpPWpGaD
